Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
16.77
+0.60 (3.71%)
Mar 25, 2025, 4:00 PM EST - Market closed
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $836.24 million as of March 25, 2025. Its market cap has increased by 20.98% in one year.
Market Cap
836.24M
Enterprise Value
638.05M
1-Year Change
20.98%
Ranking
Category
Stock Price
$16.77
Market Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $836.24M, an increase of 33.82%. That is a compound annual growth rate of 14.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2025 | 805.84M | 31.53% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 764.91B |
| UnitedHealth Group | 469.73B |
| Johnson & Johnson | 388.08B |
| AbbVie | 356.11B |
| Novo Nordisk | 335.17B |
| AstraZeneca | 227.33B |
| Merck & Co. | 221.91B |
| Abbott Laboratories | 217.81B |